CLASS II ONGOING Device recall · Reported 6 Sep 2023 · FDA Enforcement Report

epoc BGEM Crea Test Card with epoc Host SW v3.37.3 recalled

Siemens Healthcare Diagnostics is recalling epoc BGEM Crea Test Card with epoc Host SW v3.37.3, epoc NXS SW v4.10.6, Sensor, distributed in 26 states. The recall was initiated on 1 Jun 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: 00809708072254 Siemens Material Number: 10736382 Lots: 03-23002-60 (expiry 19-Jun-2023) and 03-23056-50 (expiry 12-Aug-2023)
Quantity recalled473 ea

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2477-2023
FDA event ID
92537
Recalling firm
Siemens Healthcare Diagnostics, Norwood, MA
Classification
Class II
Status
Ongoing
Recall initiated
1 Jun 2023
FDA classified
28 Aug 2023
Reported
6 Sep 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

1 Jun 2023Recall initiated by company
28 Aug 2023Classified by FDA+88 days
6 Sep 2023Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

There is potential for discrepant high glucose results in samples with glucose results on the lower end of the reportable range.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

epoc BGEM Crea Test Card with epoc Host SW v3.37.3, epoc NXS SW v4.10.6, Sensor Configuration 41.1

Where it was distributed

US distribution to AL, AR, AZ, CA, CO, DC, DE, FL, IA, ID, IL, KS, KY, LA, MI, MN, MO, NC, ND, NH, NY, OH, OK, SC, SD, and TX OUS distribution to Canada, China, Colombia, Finland, India, Mexico, Norway, Sweden, United Arab Emirates, and Vietnam

AlabamaArkansasArizonaCaliforniaColoradoDistrict of ColumbiaDelawareFloridaIowaIdahoIllinoisKansasKentuckyLouisianaMichiganMinnesotaMissouriNorth CarolinaNorth DakotaNew Hampshire

Questions about this recall

Why was it recalled?

There is potential for discrepant high glucose results in samples with glucose results on the lower end of the reportable range.

Which lots are affected?

UDI-DI: 00809708072254 Siemens Material Number: 10736382 Lots: 03-23002-60 (expiry 19-Jun-2023) and 03-23056-50 (expiry 12-Aug-2023)

Where was it sold?

US distribution to AL, AR, AZ, CA, CO, DC, DE, FL, IA, ID, IL, KS, KY, LA, MI, MN, MO, NC, ND, NH, NY, OH, OK, SC, SD, and TX OUS distribution to Canada, China, Colombia, Finland, India, Mexico, Norway, Sweden, United Arab Emirates, and Vietnam

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 92537

More recalls from Siemens Healthcare Diagnostics

All 694

Other Other Medical Devices recalls

All 13,778